Colorectal cancer with synchronous distant metastases: rationale for cytoreductive surgery and its perspectives – a surgeons view

A rationale for cytoreductive surgery in colorectal cancer patients with multiple liver metastases is discussed in the article. Not only does it improve their quality of life and prevent life-threatening complications, but also facilitates further systemic treatment. Symptomatic surgery (colostomies and bypass surgery) does not improve treatment outcome independent from additional treatment. Our results demonstrate that chemotherapy with 2 or more active drugs after cytoreductive surgery significantly improves treatment results. Rationale for the use of chemoradiotherapy in rectal cancer patients with synchronous distant metastases is demonstrated in the article.

1. Davydov M.I., Aksel' E.M. Statistika zlokachestvennykh novoobrazovanii v Rossii i stranakh SNG v 2009 g. Vestnik RONTs im. N.N. Blokhina RAMN 2011;22:3(85) (pril. 1).

2. Barsukov Yu.A., Aliev V.A., Cherkes V.L. i dr. Tsitoreduktivnye operatsii pri metastaticheskom kolorektal'nom rake. Vestnik RONTs im. N.N. Blokhina RAMN

3. ;3:15-7.

4. Wittekind C., Compton C., Quirke P. et al. A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status. Cancer 2009;115(15):3483-8. https://doi.org/10.1002/cncr.24320

5. Knysh V.I. Rak pryamoi i obodochnoi kishki. M.: Meditsina, 1997. S. 5, 259-263.

6. Perevodchikova N.I. Khimioterapiya disseminirovannogo kolorektal'nogo raka. Chelovek i zdorov'e. M., 2000.

7. Patyutko Yu.I., Chuchuev E.S., Podluzhnyi D.V. i dr. Khirurgicheskaya taktika v lechenii bol'nykh kolorektal'nym rakom s sinkhronnymi metastazami v pechen'. Onkologicheskaya koloproktologiya 2011;2:13-19.

8. Tebbutt N.C., Norman A.R., Cunningham D. et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Ann Surg Oncol 2003;52(4):568-73;

9. Muratore A., Zorzi D., Bouzari H. et al. Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 2007;14(2):766-70.

10. Scheer M.G.W., Sloots C.E.J., van der Wilt G.J. et al. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann of Oncol 2008. Advance Access published July 28.

11. Scoggins C.R., Meszoely I.M., Blanke C.D. et al. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999;6(7):651-7.

12. Naredi P. Databases of hepatic resection for metastatic colorectal cancer--useful aids

13. for clinical decision-making. Surg Oncol 2008 Jul;17(1):15-6. Epub 2008 Jan 9.

14. Nash G.M., Saltz L.B., Kemeny N.E. et al. Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 2002 Dec;9(10):954-60.

15. Ruo L., DeMatteo R.P., Blumgart L.H. The role of adjuvant therapy after liver resection for colorectal cancer metastases. Clin Colorectal Cancer 2001 Nov;1(3):154-66; discussion 167-8.

16. Galizia G., Lieto E., Orditura M. et al. First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg 2008 Apr;143(4):352-8; discussion 358.

17. Tveit K.M., Guren T., Glimelius B. et al. Phase III trial of cetuximab with continuous

18. or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study. J Clin Oncol 2012 May 20; 30(15):1755-62. Epub 2012 Apr 2.

19. Maughan T.S., Adams R.A., Smith C.G. et al. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet 2011 Jun 18;377(9783):2103-14. Epub 2011 Jun 5.

20. Savina I.A, Moiseenko V.M., Vasil'ev S.V., Simonov N.N. Pokazateli vyzhivaemosti bol'nykh rakom obodochnoi kishki s otdalennymi metastazami posle

21. operatsii razlichnogo ob"ema. Voprosy onkologii 2003;49(3):340-5.

22. van Dijk T.H. et al. Short-course radiation therapy, neoadjuvant bevacizumab, capecitabine and oxaliplatin, and radical resection of primary tumour and metastases in primary stage IV rectal cancer. Ann of Oncol 2010;21(suppl 1) post 98, p. 51.

23. Suarez J. et al. Chemotherapy vs chemoradiotherapy as neoadjuvant treatment for metastatic rectal cancer: a study of local control. Ann of Oncol 2010;21(suppl 1) post 85, p. 46.

24. Bokhman Ya.V, Livshits M.A., Vinokurov V.L. Novye podkhody k lecheniyu ginekologicheskogo raka. SPb.: Gippokrat, 1993. S. 18.

25. Adam R. The importance of visceral metastasectomy in colorectal cancer. Ann

26. Oncol 2000;11:29-36.

27. Poston G. Overview of colorectal cancer with synchronous liver metastases: what

28. order of treatment. 14th Congress of the ESSO Hague, Netherlands. Eur J Surg Oncol 2008;9(poster 175):1040.

29. Sekacheva M.I., Polishchuk L.O., Bagmet N.N., Skipenko O.G. Rezul'taty khirurgicheskogo lecheniya metastaticheskogo kolorektal'nogo raka posle provedeniya

30. lekarstvennoi terapii s dobavleniem bevatsizumaba. Sovremennaya onkologiya

31. ;2(14):38.

32. Vashakmadze L.A., Sidorov D.V., Trakhtenberg A.Kh. i dr. Tsitoreduktivnye

33. operatsii v lechenii metastaticheskogo kolorektal'nogo raka. Materialy

34. VI Vserossiiskogo s"ezda onkologov. Rostov-na-Donu, 2005. S. 279-280.

35. Simonov N.N. Khirurgicheskoe lechenie raka pryamoi kishki pri nalichii

36. otdalennykh metastazov. Prakticheskaya onkologiya 2002;2(3):130-3.

37. Barsukov Yu.A., Tkachev S.I., Nikolaev A.V. i dr. Kombinirovannoe

38. i kompleksnoe lechenie raka pryamoi kishki. Metodicheskie rekomendatsii.

39. M.: Izd. gruppa RONTs, 2011.

40. Berdov B.A., Pochuev T.P. Rol' luchevoi terapii v lechenii pervichnoi opukholi u bol'nykh kolorektal'nym rakom s sinkhronnymi metastazami v pechen'.

41. Materialy V s"ezda onkologov i radiologov SNG, Tashkent, 2008. S. 503.